188 related articles for article (PubMed ID: 29753956)
1. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment.
Teruel AH; Pérez-Esteve É; González-Álvarez I; González-Álvarez M; Costero AM; Ferri D; Parra M; Gaviña P; Merino V; Martínez-Mañez R; Sancenón F
J Control Release; 2018 Jul; 281():58-69. PubMed ID: 29753956
[TBL] [Abstract][Full Text] [Related]
2. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease.
Teruel AH; Pérez-Esteve É; González-Álvarez I; González-Álvarez M; Costero AM; Ferri D; Gaviña P; Merino V; Martínez-Máñez R; Sancenón F
Mol Pharm; 2019 Jun; 16(6):2418-2429. PubMed ID: 30991003
[TBL] [Abstract][Full Text] [Related]
3. Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device.
Teruel AH; Coll C; Costero AM; Ferri D; Parra M; Gaviña P; González-Álvarez M; Merino V; Marcos MD; Martínez-Máñez R; Sancenón F
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439396
[TBL] [Abstract][Full Text] [Related]
4. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon.
Ferri D; Gaviña P; Parra M; Costero AM; El Haskouri J; Amorós P; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
R Soc Open Sci; 2018 Aug; 5(8):180873. PubMed ID: 30225077
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis.
Ferri D; Costero AM; Gaviña P; Parra M; Merino V; Teruel AH; Sancenón F; Martínez-Máñez R
Int J Pharm; 2019 Apr; 561():93-101. PubMed ID: 30817986
[TBL] [Abstract][Full Text] [Related]
7. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Biopharm; 2009 May; 72(1):1-8. PubMed ID: 19348015
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
[TBL] [Abstract][Full Text] [Related]
9. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
[TBL] [Abstract][Full Text] [Related]
11. ϵ-Polylysine-Capped Mesoporous Silica Nanoparticles as Carrier of the C9h Peptide to Induce Apoptosis in Cancer Cells.
de la Torre C; Domínguez-Berrocal L; Murguía JR; Marcos MD; Martínez-Máñez R; Bravo J; Sancenón F
Chemistry; 2018 Feb; 24(8):1890-1897. PubMed ID: 29193344
[TBL] [Abstract][Full Text] [Related]
12. Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota.
Cheng S; Shen H; Zhao S; Zhang Y; Xu H; Wang L; Di B; Xu L; Hu C
Nanoscale; 2020 Jul; 12(28):15348-15363. PubMed ID: 32648873
[TBL] [Abstract][Full Text] [Related]
13. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
Sarkate A; Dhaneshwar SS
World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
[TBL] [Abstract][Full Text] [Related]
14. Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles.
Zhou S; Sha H; Ke X; Liu B; Wang X; Du X
Chem Commun (Camb); 2015 Apr; 51(33):7203-6. PubMed ID: 25811958
[TBL] [Abstract][Full Text] [Related]
15. Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Hossain MA; Yamashita M; Vong LB; Ikeda Y; Nagasaki Y
J Drug Target; 2014 Aug; 22(7):638-47. PubMed ID: 24955616
[TBL] [Abstract][Full Text] [Related]
16. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
17. Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon.
Naeem M; Kim W; Cao J; Jung Y; Yoo JW
Colloids Surf B Biointerfaces; 2014 Nov; 123():271-8. PubMed ID: 25266978
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
19. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
20. Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies.
Ansari L; Jaafari MR; Bastami TR; Malaekeh-Nikouei B
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):594-606. PubMed ID: 29688064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
